As we included participants with a very low likelihood of fibrosis based on their FIB-4 scores, our findings might suggest that—similar to kATP—PME/PDE and NADPH might be markers of disease severity in NAFLD. Here, ALDH7A1 is linked to metabolic dysfunction-associated steatotic liver disease.